undefined undefined
NaN.000
NaN.00%
Immunome (IMNM) has issued an update. Bob Lapetina is set to depart from his ex...
05-01 04:12
Gainers: Cyclacel Pharmaceuticals Inc (CYCC) +60% FORM 10-K/A | Amended Annual Report. Auddia Inc (AUUD) +34% Announces Strategic Product Expansion With Cloud Based Artificial Intelligence and Natural...
04-30 20:42
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences...
04-27 03:15
An announcement from Immunome (IMNM) is now available. Immunome, Inc. has appoi...
04-26 04:12
In the last three months, 12 analysts have published ratings on Gilead Sciences...
04-20 03:00
NEW YORK, April 17, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 IS...
04-18 07:45
Wedbush analyst David Nierengarten maintains Immunome (NASDAQ:IMNM) with a Outperform and raises the price target from $27 to $33.
04-01 19:58
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-01 19:57
Wedbush analyst David Nierengarten maintained a Buy rating on Immunome (IMNM – ...
04-01 19:55
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 76.56 percent increase over losses of $(0.64) per share from the same
03-29 11:37